Autoimmune chronic spontaneous urticaria
Journal of Allergy and Clinical Immunology2022Vol. 149(6), pp. 1819–1831
Citations Over TimeTop 1% of 2022 papers
Pavel Kolkhir, Melba Muñoz, Riccardo Asero, Marta Ferrer, Emek Kocatürk, Martin Metz, Yi‐Kui Xiang, Marcus Maurer
Related Papers
- → Effect of omalizumab on angioedema in H 1 ‐antihistamine‐resistant chronic spontaneous urticaria patients: results from X‐ ACT , a randomized controlled trial(2016)128 cited
- → IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms(2022)50 cited
- → Omalizumab in recurring larynx angioedema: a case report(2014)20 cited
- → Development of Assay for Determining Free IgE Levels in Serum from Patients Treated with Omalizumab(2014)20 cited
- → Private Practice Experience with Omalizumab for Chronic Urticaria(2020)